We are providing electronically activated purification of biomolecules for biopharmaceutical and protein production. By utilizing our patent-pending invention, we build functionalized polymer surfaces that can with high specificity and high capacity capture and release biomolecules at the press of a button. Making today's complex biopharmaceutical and protein manufacturing simpler, more effective, and digital.
Location: Sweden, Gothenburg
Employees: 1-10
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | BioVenture... | azbioventu... |
| - | Chalmers V... | chalmersve... |
Mentions in press and media 1
| Date | Title | Description |
| 03.12.2024 | Nyctea Technologies brings electrified purification to drug development to accelerate medical innovation | Nyctea Technologies brings electrified purification to drug development to accelerate medical innovation Tue, Dec 03, 2024 09:15 CET Report this content Founded at Chalmers University and funded by Chalmers Ventures, Nyctea Technologies use... |